Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Biomaterials
|
February 26, 2022
Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption
Phillip W Janowicz, Zachary H Houston, Jens Bunt, et al.
Scientific Reports
|
July 20, 2023
An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage
Michael Agrez, Mark Stephen Rybchyn, Warusavithana Gunawardena Manori De Silva, et al.
Advanced Healthcare Materials
|
March 15, 2019
Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies
Jiwei Cui, Yi Ju, Zachary H Houston, et al.
Science Translational Medicine
|
May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia
Ernest Moles, Christopher B Howard, Pie Huda, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Biomaterials
|
February 26, 2022
Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption
Phillip W Janowicz, Zachary H Houston, Jens Bunt, et al.
Scientific Reports
|
July 20, 2023
An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage
Michael Agrez, Mark Stephen Rybchyn, Warusavithana Gunawardena Manori De Silva, et al.
Advanced Healthcare Materials
|
March 15, 2019
Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies
Jiwei Cui, Yi Ju, Zachary H Houston, et al.
Science Translational Medicine
|
May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia
Ernest Moles, Christopher B Howard, Pie Huda, et al.
Page
of 8